AtriCure (ATRC) Stock Analysis & Winston Score
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation an
Winston Score: 35/100 — Below Average
Below-average fundamentals — multiple weak pillars.
- Quality: Mixed (13/30)
- Growth: Mixed (7/20)
- Cash Flow: Weak (2/10)
- Stability: Good (5/10)
- Valuation: Data not available (0/10)
- Ownership: Mixed (6/15)
Key Facts
Price: $34.95
Market Cap: $1.8B
Sector: Healthcare
Industry: Medical - Instruments & Supplies
Exchange: NASDAQ

